key: cord-0701861-gton069r
authors: Lednicky, J. A.; Lauzardo, M.; Alam, M. M.; Elbadry, M.; Stephenson, C.; Gibson, J. C.; Morris, J. G.
title: Isolation of SARS-CoV-2 from the air in a car driven by a COVID patient with mild illness
date: 2021-01-15
journal: nan
DOI: 10.1101/2021.01.12.21249603
sha: 78b2314554fdce9e74ac02379f6dc3800b75a60d
doc_id: 701861
cord_uid: gton069r

We used a Sioutas personal cascade impactor sampler (PCIS) to screen for SARS-CoV-2 in a car driven by a COVID-19 patient. SARS-CoV-2 was detectable at all PCIS stages by PCR and was cultured from the section of the sampler collecting particles in the 0.25 to 0.50 m size range.

While we have learned a great deal about transmission of SARS-CoV-2 since the beginning of the current pandemic, questions remain about the exposure risk in different settings, and the contribution of various modes of transmission to virus spread. 1 In particular, there is continuing uncertainty about the relative contribution of larger virus-laden respiratory particles at close distances, compared with virions in aerosols at close or longer ranges, to spread of the virus.

There are now multiple epidemiology studies consistent with aerosol spread of SARS-CoV-2 within closed spaces, 2,3 and the virus has been shown to remain infective in laboratorygenerated aerosols for at least 16 hours. 4 Data from our group and others have documented the presence of the virus in aerosols in patient settings by RT-PCR. [5] [6] [7] However, molecular detection of SARS-CoV-2 RNA does not necessarily correlate with risk of developing COVID-19, since only viable virions can cause disease. Subsequently, we have reported isolation of viable SARS-CoV-2 from the air within the room of hospitalized COVID-19 patients. 8 The current study was undertaken to assess SARS-CoV-2 transmission in a "real life" setting, outside of a medical facility. In epidemiologic studies, public transportation vehicles have been identified as a risk factor for transmission by CDC, and studies from Singapore have reported an odds ratio for infection of 3.07 [95% CI 1.55-6.08] for persons sharing a vehicle with an infected person. 9 In this setting, we were interested in documenting that viable virus could be isolated from the air of a car being driven by a person infected with SARS-CoV-2. We were also interested in determining the size distribution of airborne respiratory secretions that contain virions to provide some guide to the contribution of droplets and aerosols to transmission risk.

To do this, we asked a COVID patient with minimal symptoms to drive her car for a short period of time with a Sioutas personal cascade impactor sampler (PCIS) 10 clipped onto the sun-visor above the passenger seat next to her. The Sioutas PCIS separates airborne particles in a cascading fashion and simultaneously collects the size-fractionated particles by impaction on polytetrafluoroethylene (PTFE) filters. It has collection filters on four impaction stages (A-D), . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted January 15, 2021. ; https://doi.org/10.1101/2021.01.12.21249603 doi: medRxiv preprint and an optional after-filter can be added onto a 5th stage (E). The PCIS separates and collects airborne particulate matter above the cut-point of five size ranges: >2.5 The patient, who was in her twenties, had initially presented to clinic with a one-day history of mild fatigue, nasal congestion, and sore throat, following exposure to a roommate who had a laboratory-confirmed diagnosis of COVID-19. The patient denied fever, cough, shortness of breath, or other symptoms, and had a normal physical exam. In testing performed by the UFHealth clinical laboratory, a nasopharyngeal swab collected at the time of presentation was positive by RT-PCR. The patient was advised to isolate at home for a 10-day period of time, and appropriate contact tracing was initiated.

Two days after the diagnostic sample was obtained, the patient agreed to have the PCIS placed on the passenger seat of her car (an older model Honda Accord) for the drive from the clinic to her home. Her symptoms at that time were minimal, with no cough. The PCIS was attached to the sun-visor on the passenger side of the car, approximately 3 feet from the patient's face and with the intake port pointing toward the roof of the car. During the 15-minute drive the patient was not wearing a mask. The air conditioner in the car was on: during the drive the temperature within the car's cabin ranged from 24.2 to 22.8 °C and relative humidity fluctuated from 55.2 to 42.5%; outside temperature was 32 °C and relative humidity 99%.

Two hours after the patient's arrival home, an investigator wearing personal protective equipment (N95 mask, gloves, and a Tyvek laboratory coat) opened the car and turned off the . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted January 15, 2021. ; https://doi.org/10.1101/2021.01.12.21249603 doi: medRxiv preprint pump of the air sampler, and transferred the PCIS-pump assembly into a sealed container and decontaminated the outer surface of the container; the calculated amount of air filtered from inside the vehicle was approximately 1.2 m 3 . After removal from the car, the air sampling assembly was transported with appropriate biosafety precautions to a BSL2-enhanced laboratory at the University of Florida. Within 30 minutes of the termination of air-sampling, the PCIS filters were individually immersed in 1 ml of recovery solution (PBS with 0.5% w/v BSA fraction V and 0.2 M surcose 11 ) for 30 minutes at room temperature, and then scraped with flocked swabs pre-wetted with recovery solution. Samples were concentrated by centrifugation and stored at -80°C.

After one thaw on ice, RNA was extracted from 140 µl of material extruded off the PCIS filters using a QIAamp Viral RNA Mini Kit. rRT-PCR to detect SARS-CoV-2 RNA was performed using primer system Led-N-F, Led-N-R, and Led-N-probe. 11 The number of viral genome equivalents present in each sample was estimated from the measured quantification cycle (Cq) values, and was attained using 10-fold dilutions of calibrated plasmids containing an insert of the SARS-CoV-2 N-gene as previously described. 8 SARS-CoV-2 RNA was detected on filters A to D, suggesting that the PCIS had collected a range of particle sizes containing SARS-CoV-2 virions or other material (possibly cell debris) containing SARS-CoV-2 RNA ( Table 1 ). More of the SARS-CoV-2 RNA material was collected on filter D than that on filters A-C and E combined.

Filter material was subsequently inoculated onto Vero E6 cells as previously described. 8 Early cytopathic effects consistent with those caused by SARS-CoV-2 were observable by 3 days in cells inoculated with material collected onto PCIS filter D; by day 5, foci of infection were apparent for cells inoculated with material from filter D (Supplemental Figure 1C . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted January 15, 2021. ; https://doi.org/10.1101/2021.01.12.21249603 doi: medRxiv preprint 1 0 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted January 15, 2021. ; https://doi.org/10.1101/2021.01.12.21249603 doi: medRxiv preprint 1 1 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted January 15, 2021. ; https://doi.org/10.1101/2021.01.12.21249603 doi: medRxiv preprint 1 2 is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted January 15, 2021. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted January 15, 2021. ; https://doi.org/10.1101/2021.01.12.21249603 doi: medRxiv preprint 1 4

Within 30 minutes of the termination of air-sampling, the PCIS filters were individually immersed in 1 ml of recovery solution (PBS with 0.5% w/v BSA fraction V and 0.2 M surcose) 4 for 30 minutes at room temperature to help rehydrate and dislodge virions stuck on the filter surfaces.

The filters and fluid were then transferred to a sterile plastic petri dish, and the filters scraped is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted January 15, 2021. ; https://doi.org/10.1101/2021.01.12.21249603 doi: medRxiv preprint 1 5 from the measured quantification cycle (Cq) values, and was attained using 10-fold dilutions of calibrated plasmids containing an insert of the SARS-CoV-2 N-gene as previously described. 4 Attempts to isolate SARS-CoV-2 were performed in a BSL3 laboratory by trained analysts wearing full head-covering powered air purifying respirators and appropriate PPE. After one thaw on ice, 150 μ L aliquots of PCIS fluids were inoculated onto newly confluent Vero E6 cells, which were then incubated at 37 °C in a humidified 5% CO 2 incubator. Mock infected cells were maintained in parallel. The cells were re-fed with cell growth medium containing reduced serum (3% fetal bovine serum) every three days. 4 Early cytopathic effects consistent with those caused by SARS-CoV-2 were observable by 3 days in cells inoculated with material collected onto PCIS filter D; by day 5, foci of infection were apparent for cells inoculated with material from filter D (Supplemental Figure 1C Sanger sequencing was performed on RNA extracted from the cell growth medium corresponding to PCID filter D. As a secondary check, NGS was also performed using an Illumina MiSeq platform, as previously described. 4 The sequencing reactions were performed at different locations by different personnel.

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted January 15, 2021. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted January 15, 2021. ; https://doi.org/10.1101/2021.01.12.21249603 doi: medRxiv preprint

The engines of SARS-CoV-2 spread

Coronavirus Disease Outbreak in Call Center

High SARS-CoV-2 attack rate following exposure at a choir practice

Persistence of Severe Acute Respiratory Syndrome Coronavirus 2 in Aerosol Suspensions. Emerg Infect Dis

Sampling and detection of corona viruses in air: A mini review

Collection of SARS-CoV-2 virus from the air of a clinic within a university student health care center and analyses of the viral genomic sequence. Aerosol and Air Quality Res

Aerosol and surface contamination of SARS-CoV-2 observed in quarantine and isolation care

International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity

Viable SARS-CoV-2 in the air of a hospital room with COVID-19 patients

SARS-CoV-2 seroprevalence and transmission risk factors among high-risk close contacts: a retrospective cohort study

Detection and Isolation of Airborne Influenza A H3N2 Virus Using a Sioutas Personal Cascade Impactor Sampler

Collection, particle sizing and detection of airborne viruses

Methods for sampling of airborne viruses

International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity

Development and evaluation of a personal cascade impactor sampler (PCIS)

Detection and Isolation of Airborne Influenza A H3N2 Virus Using a Sioutas Personal Cascade Impactor Sampler

An optimized method to detect influenza virus and human rhinovirus from exhaled breath and the airborne environment

Viable SARS-CoV-2 in the air of a hospital room with COVID-19 patients